Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sainger, Rachana N.a; d | Shah, Franky D.a | Telang, Shaila D.b | Shah, Pankaj M.c | Patel, Prabhudas S.a; *
Affiliations: [a] Biochemistry Research Division, The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, 380 016, India | [b] Department of Biochemistry, M.S. University of Baroda, Vadodara, 390 001, India | [c] The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, 380 016, India | [d] Division of Cancer Biology, Department of Medicine, ENH Research Institute, Evanston, IL 60201, USA
Correspondence: [*] Corresponding author: Dr. Prabhudas S. Patel, Head, Biochemistry Research Division, The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, 380 016, India. Tel.: +91 792268369; Fax: +91 79 22685490; E-mail: [email protected].
Abstract: Telomere attrition is an important event during tumorigenesis regulated by factors including oxidative stress, mitochondrial function, DNA adducts etc. Critically short telomeres act as signal for telomerase activity in the cancer cells. To determine whether null genotype of GSTM1 gene has any association with telomere length shortening and telomerase activity, we analyzed telomere length, telomerase activity and GSTM1 polymorphism in oral tissues. We observed that malignant tissues exhibited shorter telomere length. Telomerase activity was observed in about 75% malignant tissues. 40% of the oral cancer patients exhibited GSTM1 polymorphism. Further, shorter telomere lengths were observed in patients having GSTM1 polymorphism. Also, the GSTM1 genotype showed negative correlation with telomerase activity and telomere length. Our study proposes role of GSTM1 polymorphism in telomere attrition and subsequent telomerase activity in the cancer cells. The results are suggestive of possible link between absence of GSTM1 gene and telomere length alterations.
Keywords: Telomere attrition, telomerase activity, GSTM1 polymorphism, oral cancer
DOI: 10.3233/CBM-2009-0103
Journal: Cancer Biomarkers, vol. 5, no. 4-5, pp. 189-195, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]